Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance (Q36246116)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance |
scientific article |
Statements
1 reference
Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance (English)
1 reference
Ilias Stagakis
1 reference
George Bertsias
1 reference
Stylianos Karvounaris
1 reference
Melina Kavousanaki
1 reference
Dimitra Virla
1 reference
Amalia Raptopoulou
1 reference
Dimitrios Kardassis
1 reference
Dimitrios T Boumpas
1 reference
Prodromos I Sidiropoulos
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference